688670.SH
金迪克
SSE · Healthcare · Biotechnology · CN
CNY 15.01
−5.89%Aug 20, 2026, 12:23 UTC
Jindike announced its H1 2026 results: revenue fell 74.15% year-on-year to 0.9109 million yuan, and net loss attributable to shareholders widened to 51.0704 million yuan from 39.6531 million yuan a year earlier.
Source: